Africa Western and Central vs Egypt: Immunization, Hib3
Africa Western and Central
74.3%
in 2024
Egypt
97.0%
in 2024
Africa Western and Central rank
31st
Egypt rank
29th
Immunization, Hib3 over time
- Africa Western and Central
- Egypt
How they compare
Egypt currently reports 97.0% against 74.3% in Africa Western and Central, a difference of 22.7%.
That makes Egypt's figure about 1.3 times Africa Western and Central's.
Across all 11 years both countries report, Egypt has been ahead every year.
Africa Western and Central ranks 31st and Egypt ranks 29th of 43 groups.
Egypt has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Africa Western and Central | Egypt | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 66.0% | 94.3% | 28.4% | Egypt |
| 2020s | 71.4% | 96.0% | 24.6% | Egypt |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher immunization, hib3, Africa Western and Central or Egypt?
- Egypt, at 97.0% against 74.3% in Africa Western and Central as of 2024.
- What is the difference in immunization, hib3 between Africa Western and Central and Egypt?
- 22.7%, with Egypt ahead.
- How many years of comparable data are there for Africa Western and Central and Egypt?
- 11 years are reported by both, from 2014 to 2024.
- How do Africa Western and Central and Egypt rank globally for immunization, hib3?
- Africa Western and Central ranks 31st and Egypt ranks 29th of 43 groups.
- Where does this data come from?
- WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as Immunization, Hib3 (% of children ages 12-23 months). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Child immunization, Hib3, measures the percentage of children ages 12-23 months who received Hib3 vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized against Hib3 after receiving three doses of Haemophilus influenzae type b vaccine.